RC
GILD icon

Rovin Capital’s Gilead Sciences GILD Stock Holding History

Rovin Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,925
Closed -$213K – 197
2025
Q2 		$213K Sell
1,925
-2,256
-54% -$240K 0.06% 181
2025
Q1 		$468K Sell
4,181
-2,770
-40% -$286K 0.15% 111
2024
Q4 		$642K Sell
6,951
-2,708
-28% -$244K 0.23% 73
2024
Q3 		$810K Buy
9,659
+1,226
+15% +$93.5K 0.3% 69
2024
Q2 		$579K Buy
8,433
+966
+13% +$64.5K 0.24% 84
2024
Q1 		$547K Sell
7,467
-6
-0.1% -$461 0.22% 90
2023
Q4 		$605K Buy
7,473
+1,765
+31% +$137K 0.27% 72
2023
Q3 		$428K Buy
5,708
+2,604
+84% +$200K 0.2% 74
2023
Q2 		$239K Sell
3,104
-456
-13% -$36.4K 0.11% 115
2023
Q1 		$295K Sell
3,560
-4,094
-53% -$339K 0.14% 101
2022
Q4 		$657K Sell
7,654
-1,257
-14% -$99.5K 0.33% 53
2022
Q3 		$550K Sell
8,911
-1,821
-17% -$115K 0.32% 49
2022
Q2 		$663K Buy
10,732
+544
+5% +$33.7K 0.45% 39
2022
Q1 		$606K Buy
10,188
+172
+2% +$11K 0.32% 48
2021
Q4 		$727K Buy
+10,016
New +$690K 0.35% 39

Other funds holding GILD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Rovin Capital's GILD Position: Q3 2025 in Review

Rovin Capital sold out of Gilead Sciences (GILD) in Q3 2025, closing a stake of 1,925 shares — an estimated $213K sold.

Rovin Capital first reported a position in GILD in Q4 2021 and held it in 15 quarters. The position peaked at $810K in Q3 2024. 2,026 funds tracked by Wall St. Rank hold GILD as of Q3 2025.

  • Rovin Capital reported no remaining Gilead Sciences position as of Q3 2025 after selling out during the quarter.
  • Rovin Capital sold 1,925 Gilead Sciences shares in Q3 2025, an estimated $213K.
  • Rovin Capital first reported a position in Gilead Sciences in Q4 2021 and held it in 15 quarters.
  • Rovin Capital's Gilead Sciences position peaked at $810K in Q3 2024.
  • 2,026 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2025.

Based on Rovin Capital's 13F filing for Q3 2025, filed 17 Oct 2025.